Future studies will be required to determine how to achieve the maximum tumor-suppressive effect from p53 Y220C–stabilizing compounds, which could be achieved through combination with cell-cycle inhibitors, proapoptotic drugs, or therapeutic hypothermia (21). Here, TP53 is linked to neoplasm.